SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-019523
Filing Date
2019-12-20
Accepted
2019-12-20 16:03:18
Documents
79
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1220065
2 ex31-1.htm EX-31.1 20067
3 ex31-2.htm EX-31.2 20653
4 ex32-1.htm EX-32.1 6984
5 ex32-2.htm EX-32.2 6790
6 image_001.jpg GRAPHIC 74204
  Complete submission text file 0001493152-19-019523.txt   5404125

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE adxs-20191031.xml EX-101.INS 835901
8 XBRL SCHEMA FILE adxs-20191031.xsd EX-101.SCH 54794
9 XBRL CALCULATION FILE adxs-20191031_cal.xml EX-101.CAL 82078
10 XBRL DEFINITION FILE adxs-20191031_def.xml EX-101.DEF 197753
11 XBRL LABEL FILE adxs-20191031_lab.xml EX-101.LAB 429581
12 XBRL PRESENTATION FILE adxs-20191031_pre.xml EX-101.PRE 341307
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-36138 | Film No.: 191301132
SIC: 2834 Pharmaceutical Preparations